Exact Sciences (EXAS) Income from Continuing Operations (2016 - 2025)
Historic Income from Continuing Operations for Exact Sciences (EXAS) over the last 17 years, with Q3 2025 value amounting to -$19.6 million.
- Exact Sciences' Income from Continuing Operations rose 4875.51% to -$19.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$986.6 million, marking a year-over-year decrease of 36085.67%. This contributed to the annual value of -$1.0 billion for FY2024, which is 40397.36% down from last year.
- Per Exact Sciences' latest filing, its Income from Continuing Operations stood at -$19.6 million for Q3 2025, which was up 4875.51% from -$1.2 million recorded in Q2 2025.
- Exact Sciences' Income from Continuing Operations' 5-year high stood at $794000.0 during Q3 2023, with a 5-year trough of -$864.6 million in Q4 2024.
- Over the past 5 years, Exact Sciences' median Income from Continuing Operations value was -$101.2 million (recorded in 2025), while the average stood at -$135.5 million.
- Its Income from Continuing Operations has fluctuated over the past 5 years, first soared by 10053.37% in 2023, then crashed by 491561.71% in 2024.
- Over the past 5 years, Exact Sciences' Income from Continuing Operations (Quarter) stood at -$220.6 million in 2021, then skyrocketed by 42.09% to -$127.8 million in 2022, then soared by 61.05% to -$49.8 million in 2023, then plummeted by 1637.3% to -$864.6 million in 2024, then skyrocketed by 97.73% to -$19.6 million in 2025.
- Its Income from Continuing Operations stands at -$19.6 million for Q3 2025, versus -$1.2 million for Q2 2025 and -$101.2 million for Q1 2025.